It was shown in colorectal cancer to restore WT p53 signaling and destabilize mutant p53 at non-genotoxic doses, with subsequent experiments in head and neck squamous cell carcinoma showing similar effects (39, 41). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.